Reach Us +32 25889658

Abstract

SCAR2.0 Treating Refractory B Cell Lymphomas: An advanced Technology Saves More Lives!

CAR-T cell therapy represents an innovative and effective therapy for patients with refractory/relapsed B cell malignancies. However, many limitations remain with the currently approved CAR-T products, including antigen escape, CAR-T exhaustion in vivo, significant toxicity, and high cost, to name a few.


Author(s):

Cheng Jiao* and Lung-Ji Chang



Abstract | PDF

Share this  Facebook  Twitter  LinkedIn  Google+

paper.io

agar io

wowcappadocia.com
cappadocia-hotels.com
caruscappadocia.com
brothersballoon.com
balloon-rides.net

wormax io